Transcription factor AP-1 regulates TGF-β1-induced expression of aldose reductase in cultured human mesangial cells

Nephrology

Volumn 13, Issue 3, 2008, Pages 212-217

  Jiang, Tao ^a   Qu, Jie J ^a   Nishinaka, Toru ^b   Zhang, Nong ^a  

^a FUDAN UNIVERSITY   (China)

^b OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

Aldose reductase; AP 1; MAP Kinase; Mesangial cell; TGF 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALDEHYDE REDUCTASE; MITOGEN ACTIVATED PROTEIN KINASE; SP 6000125; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG MECHANISM; GENE MUTATION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 40349112828     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00913.x     Document Type: Article

References (31)

1. 1 Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo‐keto reductase superfamily. Biochem. Pharmacol. 1997 ; 54: 639–47.
2. 2 Yabe‐Nishimura C. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998 ; 50: 21–33.
3. 3 He Q, Khanna P, Van Srivastava SKF, Ansari NH. Reduction of 4‐hydroxynonenal and 4‐hydroxyhexenal by retinal aldose reductase. Biochem. Biophys. Res. Commun. 1998 ; 247: 719–22.
4. 4 Sato S, Sugiyama K, Carper D. Aldose reductase as dihydrodiol dehydrogenase: Naphthoquinone formation by rat lens aldose reductase. Adv. Exp. Med. Biol. 1997 ; 414: 499–505.
5. 5 Schnaper HW, Robson AM. Nephrotic syndrome: Minimal change disease, focal glomerulosclerosis and related disorders. In: Schrier RW, Gottschalk CW (eds). Diseases of the Kidney, 6th edn. Boston, MA: Little, Brown, 1996 ; 1725–80.
6. 6 Schnaper HW. Focal segmental glomerulosclerosis. In: Neilson EC, Couser W (eds). Immunologic Renal Diseases. New York: Lippencote‐Raven, 1997 ; 1003–26.
7. 7 Yamamoto T, Noble NA, Cohen AH et al. Expression of transforming growth factor‐β isoforms in human glomerular diseases. Kidney Int. 1996 ; 49: 461–9.
8. 8 Lin WS, Zhang N, Qin R et al. Effect of aldose reductase expression by transforming growth factor‐β1 on rat mesangial cell. Natl. Med. J. China 2001 ; 81: 744–7. (In Chinese.)
9. 9 Jiang T, Che Q, Lin YF, Li H, Zhang N. Aldose reductase regulates TGF‐β1‐induced production of fibronectin and type IV collagen in cultured rat mesangial cells. Nephrology 2006 ; 11: 105–12.
10. 10 Hsu D, Guo Y, Peifley KA, Winkles JA. Differential control of murine aldose reductase and fibroblast growth factor (FGF) regulated‐1 gene expression in NIH 3T3 cells by FGF‐1 treatment and hyperosmotic stress. Biochem. J. 1997 ; 328: 593–8.
11. 11 Chang KC, Paek KS, Kim HJ, Lee YS, Yabe‐Nishimura C, Seo HG. Substrate‐induced up‐regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol. Pharmacol. 2002 ; 61: 1184–91.
12. 12 Ko B, Ruepp B, Bohren KM, Gabbay KH, Chung SS. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J. Biol. Chem. 1997 ; 272: 16431–7.
13. 13 Nishinaka T, Yabe‐Nishimura C. EGF receptor‐ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 2001 ; 31: 205–16.
14. 14 Nakamura N, Obayashi H, Fujii M et al. Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Radic. Biol. Med. 2000 ; 29: 17–25.
15. 15 Seo HG, Nishinaka T, Yabe‐Nishimura C. Nitric oxide up‐regulates aldose reductase expression in rat vascular smooth muscle cells: A potential role for aldose reductase in vascular remodeling. Mol. Pharmacol. 2000 ; 57: 709–17.
16. 16 Nishinaka T, Yabe‐Nishimura C. Transcription Factor Nrf2Regulates Promoter Activity of Mouse Aldose Reductase (AKR1B3) Gene. J. Pharmacol. Sci. 2005 ; 97: 43–51.
17. 17 Yamaguchi K, Shirakabe K, Ahibuya H et al. Identification of a member of the MAPKKK family as a potential mediator of TGF‐signal transduction. Science 1995 ; 270: 2008–11.
18. 18 Cohen MM Jr. TGFβ/Smad signaling system and its pathologic correlates. Am. J. Med. Genet. 2003 ; 116A: 1–10.
19. 19 Cooper S, Ranger‐Moore J, Bowden TG. Differential inhibition of UVB‐induced AP‐1 and NF‐kappaB transactivation by components of the jun bZIP domain. Mol. Carcinog. 2005 ; 43: 108–16.
20. 20 Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth gactors/cytokines. Endocr. Rev. 2004 ; 25: 971–1010.
21. 21 Burger‐Kentischer A, Muller E, Neuhofer W, Marz. J, Thurau K, Beck F. Expression of aldose reductase, sorbitol dehydrogenase and Na + /myo‐inositol and Na + /Cl–/betaine transporter mRNAs in individual cells of the kidney during changes in the diuretic state. Pflugers Arch. 1999 ; 437: 248–54.
22. 22 Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y. Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 1987 ; 36: 240–3.
23. 23 Ishii H, Tada H, Isogai S. An aldose reductase inhibitor prevents glucose‐induced increase in transforming growth factor‐β and protein kinase C activity in cultured mesangial cells. Diabetologia 1998 ; 41: 362–4.
24. 24 Kapor‐Drezgic J, Zhou X, Babazono T, Dlugosz. JA, Hohman T, Whiteside C. Effect of high glucose on mesangial cell protein kinase C‐δ and ‐ε is polyol pathway‐dependent. J. Am. Soc. Nephrol. 1999 ; 10: 1193–203.
25. 25 Henry DN, Busik JV, Brosius FC, III, Heilig CW. Glucose transporters control gene expression of aldose reductase, PKCα and GLUT1 in mesangial cells in vitro. Am. J. Physiol. 1999 ; 277: F97–F104.
26. 26 Jiang T, Yang J, Li H, Zhao ZH, Zhang XR, Zhang N. Effect of TGF‐β 1 on aldose reductase expression in ra tmesang ia 1 cells and anti‐Thy1 glomerulonephritis. J. Clin. Exp. Pathol. 2005 ; 21: 90–94. (In Chinese.)
27. 27 Kloos DU, Choi C, Wingender E. The TGF‐β‐Smad network: Introducing bioinformatic tools. Trends Genet. 2002 ; 18: 96–103.
28. 28 Hocevar BA, Brown TL, Howe PH. TGF‐beta induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway. EMBO J. 1999 ; 18: 1345–56.
29. 29 Zdunek M, Silbiger S, Lei J et al. Protein kinase CK2 mediates TGF‐beta‐stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int. 2001 ; 60: 2097–108.
30. 30 Yabe‐Nishimura C, Nishinaka T, Iwata K, Seo HG. Up‐regulation of aldose reductase by the substrate, methylglyoxal. Chem. Biol. Interact. 2003 ; 143–144: 317–23.
31. 31 Iwata T, Sato S, Jimenez. J et al. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor‐alpha. J. Biol. Chem. 1999 ; 274: 7993–8001.